Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

Immune cell - derived microparticles contribute to the resistance of rheumatoid arthritis synovial fibroblasts to death receptor-mediated apoptosis

Authors: Mojca Frank, Meike Dahlhaus, Maria Filkova, Christoph Kolling, Beat A Michel, Diego Kyburz, Blaž Rozman, Renate E Gay, David Pisetsky, Steffen Gay, Astrid Jüngel

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Immune cell-derived microparticles (MPs) are present at increased amounts in synovial fluid of rheumatoid arthritis (RA) patients [1] and can activate disease-relevant signalling pathways in RA synovial fibroblasts (SF) [2, 3]. Increased resistance to apoptosis is one of the main characteristics of aggressive phenotype of RASF [4, 5] and MPs have been shown to mediate both pro- and anti- apoptotic effects in different target cells [6, 7]. The aim of the present study was to investigate the functional role of immune cell-derived MPs in modulating the apoptosis of SF in RA. …
Literature
1.
Berckmans RJ, Nieuwland R, Kraan MC, Schaap MC, Pots D, Smeets TJ, Sturk A, Tak PP: Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther. 2005, 7 (3): R536-544. 10.1186/ar1706.PubMedCentralCrossRefPubMed
2.
Beyer C, Pisetsky DS: The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol. 2010, 6 (1): 21-29. 10.1038/nrrheum.2009.229.CrossRefPubMed
3.
Distler JH, Jüngel A, Huber LC, Seemayer CA, Reich CF, Gay RE, Michel BA, Fontana A, Gay S, Pisetsky DS, Distler O: The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA. 2005, 102 (8): 2892-2897. 10.1073/pnas.0409781102.PubMedCentralCrossRefPubMed
4.
Pundt N, Peters MA, Wunrau C, Strietholt S, Fehrmann C, Neugebauer K, Seyfert C, van Valen F, Pap T, Meinecke I: Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent. Arthritis Res Ther. 2009, 11 (1): R16-10.1186/ar2607.PubMedCentralCrossRefPubMed
5.
Korb A, Pavenstädt H, Pap T: Cell death in rheumatoid arthritis. Apoptosis. 2009, 14 (4): 447-454. 10.1007/s10495-009-0317-y.CrossRefPubMed
6.
Distler JH, Akhmetshina A, Dees C, Jüngel A, Stürzl M, Gay S, Pisetsky DS, Schett G, Distler O: Induction of apoptosis in circulating angiogenic cells by microparticles. Arthritis Rheum. 2011, 63 (7): 2067-2077. 10.1002/art.30361.CrossRefPubMed
7.
Castellana D, Zobairi F, Martinez MC, Panaro MA, Mitolo V, Freyssinet JM, Kunzelmann C: Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 2009, 69 (3): 785-793. 10.1158/0008-5472.CAN-08-1946.CrossRefPubMed
Metadata
Title
Immune cell - derived microparticles contribute to the resistance of rheumatoid arthritis synovial fibroblasts to death receptor-mediated apoptosis
Authors
Mojca Frank
Meike Dahlhaus
Maria Filkova
Christoph Kolling
Beat A Michel
Diego Kyburz
Blaž Rozman
Renate E Gay
David Pisetsky
Steffen Gay
Astrid Jüngel
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3616

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Poster presentation

Balb/c FasKO mice develop allergic blepharitis associated with hyper-production of IgE

Poster presentation

GCIP, Id like HLH protein, negatively regulates cell proliferation of rheumatoid synovial cells via interaction with CBP

Poster presentation

Fas deficiency attenuates bone loss during antigen induced arthritis in mice

Poster presentation

Uncoupling protein 3 attenuates generation of reactive oxygen species by interacting with thioredoxin 2 in the mitochondrial intermembrane space

Oral presentation

Angiogenesis in rheumatoid arthritis: the role of fut 1

Oral presentation

Combined effects of the hedgehog pathway inhibitor LDE225 and nilotinib in a random mutagenesis screen
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits